Infants aged 0–3 months with suspected or confirmed pulmonary TB or tuberculous
peripheral lymphadenitis should be promptly treated with the standard
treatment regimens, as described in recommendation 9 or 10. Treatment may
require dose adjustment to reconcile the effect of age and possible toxicity
in young infants. The decision to adjust doses should be taken by a clinician
experienced in managing paediatric TB